Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort
Joachim Graf, Harald Abele, Markus Wallwiener, Eva J. Kantelhardt, Sara Y. Brucker, Elisabeth Simoes
{"title":"Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort","authors":"Joachim Graf, Harald Abele, Markus Wallwiener, Eva J. Kantelhardt, Sara Y. Brucker, Elisabeth Simoes","doi":"10.1007/s00404-026-08523-y","DOIUrl":null,"url":null,"abstract":"<div><h3>Key message</h3><p>In this study, half of all female patients with advanced and metastatic breast cancer reported experiencing financial difficulties. This highlights the need for gynecology and oncology specialists to also address patients’ socio-medical needs. Electronic patient-reported outcomes (ePRO) must be used to identify such areas of concern.</p><h3>Abstract</h3><h3>Purpose</h3><p>The aim was to investigate whether and to what extent female patients with advanced or metastatic breast cancer who are undergoing chemotherapy report financial difficulties due to their physical condition and/or the effects of medical treatment in relation to the German reference cohort.</p><h3>Methods</h3><p>A secondary data analysis was performed using data collected prospectively as part of the ePROCOM study. A total of <i>n</i> = 168 female patients who had answered questions regarding financial implications of the EORTC QLQ-C30 questionnaire were included in the analysis. Unpaired t tests (Welch) and Chi-square tests as well as multiple regressions were conducted. A bilateral <i>p</i> value of < 0.05 was considered statistically significant in all analyses (alpha = 0.05).</p><h3>Results</h3><p>The prevalence of financial distress was 50.0% (95%-CI 42.4%; 57.6%), defined as a response of at least 2 (“a little”) on a 4-point Likert scale. Between the reference cohort scored 4.8 and the breast cancer cohort scored 28.8, there was a significant difference of 24 ± 5.19 score points (<i>p</i> < 0.001; 95%-CI 18.81, 29.19) in financial burden. Overall, the regression model explained 27.7% of the total variance in financial burden through HRQoL, age, and civil status (<i>R</i><sup>2</sup> = 0.277).</p><h3>Conclusion</h3><p>Women with advanced or metastatic breast cancer reported substantially higher financial burden than the female German reference population. Lower HRQoL, younger age, and living alone were associated with greater financial impact. These findings support routine assessment of financial distress in those patients and suggest that ePRO-based screening may help identify patients in need of early social-medical support.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"313 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-026-08523-y.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Gynecology and Obstetrics","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00404-026-08523-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Key message
In this study, half of all female patients with advanced and metastatic breast cancer reported experiencing financial difficulties. This highlights the need for gynecology and oncology specialists to also address patients’ socio-medical needs. Electronic patient-reported outcomes (ePRO) must be used to identify such areas of concern.
Abstract
Purpose
The aim was to investigate whether and to what extent female patients with advanced or metastatic breast cancer who are undergoing chemotherapy report financial difficulties due to their physical condition and/or the effects of medical treatment in relation to the German reference cohort.
Methods
A secondary data analysis was performed using data collected prospectively as part of the ePROCOM study. A total of n = 168 female patients who had answered questions regarding financial implications of the EORTC QLQ-C30 questionnaire were included in the analysis. Unpaired t tests (Welch) and Chi-square tests as well as multiple regressions were conducted. A bilateral p value of < 0.05 was considered statistically significant in all analyses (alpha = 0.05).
Results
The prevalence of financial distress was 50.0% (95%-CI 42.4%; 57.6%), defined as a response of at least 2 (“a little”) on a 4-point Likert scale. Between the reference cohort scored 4.8 and the breast cancer cohort scored 28.8, there was a significant difference of 24 ± 5.19 score points (p < 0.001; 95%-CI 18.81, 29.19) in financial burden. Overall, the regression model explained 27.7% of the total variance in financial burden through HRQoL, age, and civil status (R2 = 0.277).
Conclusion
Women with advanced or metastatic breast cancer reported substantially higher financial burden than the female German reference population. Lower HRQoL, younger age, and living alone were associated with greater financial impact. These findings support routine assessment of financial distress in those patients and suggest that ePRO-based screening may help identify patients in need of early social-medical support.
期刊介绍:
Founded in 1870 as "Archiv für Gynaekologie", Archives of Gynecology and Obstetrics has a long and outstanding tradition. Since 1922 the journal has been the Organ of the Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. "The Archives of Gynecology and Obstetrics" is circulated in over 40 countries world wide and is indexed in "PubMed/Medline" and "Science Citation Index Expanded/Journal Citation Report".
The journal publishes invited and submitted reviews; peer-reviewed original articles about clinical topics and basic research as well as news and views and guidelines and position statements from all sub-specialties in gynecology and obstetrics.